Malini Khanna, MD
Interventional Pain Medicine · Sewell, NJNPI 1306087200
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (46.0%), education and food and beverage — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Pacira Pharmaceuticals Incorporated at 35.6% of the total.
Across 53 payments — averaging $119.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$2K
- Liberty Surgical Inc.$2K
- Eclipse Technology Solutions Inc.$752
- Si-bone, Inc.$393
- Johnson & Johnson$384
- AbbVie$301
- plus $371 from 5 others
What the payments were for
- Travel & lodging$2,91646%
- Food & beverage$1,54324%
- Education$1,87730%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 8 | $2,258 |
| Liberty Surgical Inc. | 1 | $1,877 |
| Eclipse Technology Solutions Inc. | 2 | $752 |
| Si-bone, Inc. | 7 | $393 |
| Johnson & Johnson | 24 | $384 |
| AbbVie | 3 | $301 |
| Arthrex | 3 | $283 |
| Avanos Medical | 2 | $35 |
| Ossur Americas, Inc. | 1 | $24 |
| Stryker | 1 | $16 |
| Misonix Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$2,054
How this compares
$6,336 in reported general payments places this provider in the 70th percentile of 82 interventional pain medicine providers in New Jersey.
See all interventional pain medicine providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 70 | $385 |
| Celecoxib | 37 | $281 |
| Methylprednisolone | 27 | $128 |
| Tizanidine Hcl | 21 | $87 |
| Tramadol Hcl | 26 | $65 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 15 | $60 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $38 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Sewell
- Connor McElligottSewell$4K
- Kayla SteeleSewell$3K
- Youssef JosephsonWest Deptford$496K
- Ali ValimahomedHolmdel$415K
- Saurabh DangEdgewater$157K
- Gabriele JasperBrick$114K
- Matthew LippChatham$67K
- Didier DemesminSomerset$33K
- Steve AydinFranklin Lakes$22K
- Kieran SlevinHainesport$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.